Paid Clinical Trials in New Haven, CT
As of July 2026, 850 paid clinical trials are recruiting in New Haven, Connecticut. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
New Haven offers studies at sites including Yale University for conditions such as Advanced Solid Tumor, Breast Cancer, Alcohol Use Disorder, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in New Haven
Filter results
0 clinical trials
·Clear filters·Top Research Study Locations in New Haven
Researchers run research studies in New Haven, CT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Yale University | Acute Myeloid Leukemia, Alcohol Use Disorder, Stage IV Lung Cancer AJCC v8 | 248 |
| Yale Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, NSCLC | 68 |
| Yale New Haven Hospital | Ischemic Stroke, Multiple Myeloma, NAFLD | 62 |
| Yale University School of Medicine | Alzheimers Disease, Alzheimers Disease, Familial, Colorectal Cancer | 61 |
| Yale School of Medicine | Epilepsy, Epilepsy (Treatment Refractory), Hemoglobinopathies | 43 |
| Smilow Cancer Center/Yale-New Haven Hospital | Ovarian Carcinoma, Advanced Hepatocellular Carcinoma, Anatomic Stage I Breast Cancer AJCC v8 | 19 |
| Connecticut Mental Health Center | Borderline Personality Disorder, Alcohol Use, Alcohol Use Disorder | 12 |
| Yale | AML, MDS, Acute Gastrointestinal Bleeding | 12 |
| Yale-New Haven Hospital | Acute Ischemic Stroke, Acute Myeloid Leukemia, Anemia, Sickle Cell | 12 |
| Smilow Cancer Hospital at Yale New Haven | Advanced Solid Tumor, AML, AML With Mutated NPM1 | 8 |
| GSK Investigational Site | Colonic Neoplasms, Gastrointestinal Neoplasms, HIV Infections | 7 |
| Yale Child Study Center | Speech, Anxiety Disorder of Adolescence, Autism | 7 |
| Yale New Haven Health | Chronic Kidney Diseases, Claudication, Critical Limb Ischemia | 7 |
| Musical Intervention Studios | COVID-19, Mental Health Issue, Alzheimer Disease | 6 |
| Smilow Cancer Hospital | Cancer, Sickle Cell Disease, Glioma, Malignant | 6 |
| Yale University, Yale Cancer Center | Breast Cancer, Endometrial Cancer, Ovarian Cancer | 6 |
| BLOOM | COVID-19, Mental Health Issue | 5 |
| Yale New Haven Health System | Aortic Stenosis, Heart Failure, ATTR Amyloidosis With Cardiomyopathy | 5 |
| Yale University Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, Anal Squamous Cell Carcinoma | 5 |
| Clinical Trial Site | Generalized Myasthenia Gravis, Juvenile Myoclonic Epilepsy, Lichen Planopilaris | 4 |
| Pfizer Clinical Research Unit - New Haven | Healthy Adults, Asthma, Healthy | 4 |
| Smilow Cancer Hospital - Yale New Haven Health | Breast Cancer, Advanced Non-Small Cell Lung Cancer, Advanced/Metastatic Solid Tumors | 4 |
| Yale New Haven Children's Hospital | Antibiotic Stewardship, Failed or Difficult Intubation, Sequela, Intubation Complication | 4 |
| Yale University School Of Medicine | Colorectal Neoplasms, Healthy Volunteers, Irritability Associated With Autism Spectrum Disorder | 4 |
| Yale University Yale Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, B Cell Lymphoma | 4 |
Active & Upcoming Studies in New Haven (2026)
Recruiting trials in New Haven grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (310 active studies)
- Unified Network for Integrated Fluid Collection at Yale · Yale University
- Rash & Diarrhea Prophylaxis With Capivasertib · Phase 2 · Maryam Lustberg
Neurology & pain (47 active studies)
- A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy · Phase 2, Phase 3 · Jazz Pharmaceuticals
- The Mechanism Underlying the Analgesic Effect of the Music of IBS Pain · Yale University
Cardiovascular (40 active studies)
Diabetes & metabolic (35 active studies)
Mental health & behavior (26 active studies)
- The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease · Phase 2 · Yale University
- Multi-Site Trial of Tirzepatide for Smoking Cessation · Phase 2 · University of Southern California
Vaccines (11 active studies)
HIV / STI (10 active studies)
- RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry · University of Texas Southwestern Medical Center
- Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics · Yale University
Pediatric (6 active studies)
- A Virtual Reality E-cigarette Prevention and Emotion Regulation Intervention for Adolescents · Yale University
- Human Milk Concentrating Device to Optimize Mother's Own Milk · Mother's Milk is Best
Common conditions studied in New Haven
- Advanced Solid Tumor (22 active studies)
- Breast Cancer (18 active studies)
- Alcohol Use Disorder (16 active studies)
- Acute Myeloid Leukemia (12 active studies)
- Advanced Solid Tumors (12 active studies)
- Heart Failure (12 active studies)
Leading research sponsors in New Haven
- Yale University
- National Cancer Institute (NCI)
- Children's Oncology Group
- Merck Sharp & Dohme LLC
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in New Haven?
There are approximately 850 recruiting clinical trials in New Haven, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New Haven pay participants?
Most recruiting trials in New Haven compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New Haven?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New Haven?
The most common conditions under active study in New Haven include Advanced Solid Tumor (22), Breast Cancer (18), Alcohol Use Disorder (16), Acute Myeloid Leukemia (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New Haven?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Haven on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New Haven?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New Haven?
Recruiting research sites in New Haven include Yale University, Yale Cancer Center, Yale New Haven Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New Haven right now?
The largest active categories in New Haven are Cancer & tumors (310), Neurology & pain (47), Cardiovascular (40). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.